A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 103 participants.
Also called NCT07474649
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 103 participants
- Sponsor
- Registry
-
NCT07474649
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany, Italy, Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT07474649. Allocation not applicable; no masking; primary purpose treatment. Start 2026-09-14 (actual); primary completion 2028-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
- Condition
- Coronary Atherosclerosis
- Condition
- Mixed Dyslipidemia
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Bempedoic acid
- Intervention (Drug)
- Ezetimibe
- Intervention (Drug)
- Rosuvastatin
- Intervention (Drug)
- Atorvastatin
- Lead sponsor
- Daiichi Sankyo
Record details
- Record id
cardio:ct-nct07474649- Content hash
feab97290471b4c7d0d38f52e2effb6e198c70da30bfa7dc9d328248a9906542